Charles R. Cannan

1.0k total citations
23 papers, 723 citations indexed

About

Charles R. Cannan is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Charles R. Cannan has authored 23 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Physiology. Recurrent topics in Charles R. Cannan's work include Cardiac Imaging and Diagnostics (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Cardiovascular Function and Risk Factors (5 papers). Charles R. Cannan is often cited by papers focused on Cardiac Imaging and Diagnostics (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Cardiovascular Function and Risk Factors (5 papers). Charles R. Cannan collaborates with scholars based in United States, Canada and Australia. Charles R. Cannan's co-authors include Amir Lerman, David R. Holmes, Guy S. Reeder, John C. Burnett, Bernard J. Gersh, L. Joseph Melton, Kent R. Bailey, Verghese Mathew, David Hasdai and Rick A. Nishimura and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Charles R. Cannan

23 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles R. Cannan United States 13 572 199 153 137 111 23 723
S K Yao United States 11 420 0.7× 158 0.8× 207 1.4× 79 0.6× 35 0.3× 13 686
K Matsuyama Japan 9 654 1.1× 191 1.0× 246 1.6× 328 2.4× 51 0.5× 16 866
Hisao Ogawa Japan 12 390 0.7× 85 0.4× 136 0.9× 195 1.4× 37 0.3× 15 601
Yasushige Shingu Japan 14 436 0.8× 106 0.5× 205 1.3× 62 0.5× 88 0.8× 73 691
Henri Cuénoud United States 10 283 0.5× 64 0.3× 249 1.6× 68 0.5× 58 0.5× 18 683
Keita Sano Japan 12 414 0.7× 73 0.4× 196 1.3× 94 0.7× 81 0.7× 23 632
Kozaburo Matsuyama Japan 9 529 0.9× 139 0.7× 132 0.9× 328 2.4× 15 0.1× 9 661
Genji Toda Japan 12 309 0.5× 40 0.2× 128 0.8× 67 0.5× 50 0.5× 34 528
Koshi Matsuyama Japan 12 657 1.1× 125 0.6× 145 0.9× 391 2.9× 18 0.2× 23 856
Dominic Lachance Canada 15 412 0.7× 75 0.4× 81 0.5× 51 0.4× 67 0.6× 23 555

Countries citing papers authored by Charles R. Cannan

Since Specialization
Citations

This map shows the geographic impact of Charles R. Cannan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles R. Cannan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles R. Cannan more than expected).

Fields of papers citing papers by Charles R. Cannan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles R. Cannan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles R. Cannan. The network helps show where Charles R. Cannan may publish in the future.

Co-authorship network of co-authors of Charles R. Cannan

This figure shows the co-authorship network connecting the top 25 collaborators of Charles R. Cannan. A scholar is included among the top collaborators of Charles R. Cannan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles R. Cannan. Charles R. Cannan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farina, Juan, Isabel G. Scalia, Timothy Barry, et al.. (2024). Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future. Biomedicines. 12(3). 682–682. 11 indexed citations
2.
Cannan, Charles R., Ingo Eitel, James Hare, Andreas Kumar, & Matthias G. Friedrich. (2010). Hemorrhage in the Myocardium Following Infarction. JACC. Cardiovascular imaging. 3(6). 665–668. 17 indexed citations
3.
Cannan, Charles R. & Matthias G. Friedrich. (2010). Cardiac magnetic resonance imaging: current status and future directions. Expert Review of Cardiovascular Therapy. 8(8). 1175–1189. 5 indexed citations
4.
Cannan, Charles R., Sarah Weeks, & Matthias G. Friedrich. (2010). CMR features of peri-partum cardiomyopathy. Journal of Cardiovascular Magnetic Resonance. 12(S1). 3 indexed citations
5.
Cannan, Charles R.. (2001). Antithrombotic therapy in cardiac stent patients. Current Cardiology Reports. 3(1). 78–84. 5 indexed citations
7.
Cannan, Charles R., Verghese Mathew, & Amir Lerman. (1998). New insight into coronary endothelial dysfunction: Role of endothelin. Journal of Laboratory and Clinical Medicine. 131(4). 300–305. 17 indexed citations
9.
Hasdai, David, Patricia J.M. Best, Charles R. Cannan, et al.. (1998). Acute Endothelin-Receptor Inhibition Does Not Attenuate Acetylcholine-Induced Coronary Vasoconstriction in Experimental Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 18(1). 108–113. 19 indexed citations
10.
Cannan, Charles R., Rick A. Nishimura, Guy S. Reeder, et al.. (1997). Echocardiographic Assessment of Commissural Calcium: A Simple Predictor of Outcome After Percutaneous Mitral Balloon Valvotomy. Journal of the American College of Cardiology. 29(1). 175–180. 94 indexed citations
11.
Cannan, Charles R., Stuart T. Higano, & David R. Holmes. (1997). Pacemaker Induced Mitral Regurgitation: An Alternative Form of Pacemaker Syndrome. Pacing and Clinical Electrophysiology. 20(3). 735–738. 19 indexed citations
12.
Cannan, Charles R. & Guy S. Reeder. (1996). Hypertrophic cardiomyopathy: Who is at risk?. ACC Current Journal Review. 5(1). 63–64. 2 indexed citations
13.
Cannan, Charles R., John C. Burnett, & Amir Lerman. (1996). Enhanced Coronary Vasoconstriction to Endothelin-BReceptor Activation in Experimental Congestive Heart Failure. Circulation. 93(4). 646–651. 91 indexed citations
14.
Hasdai, David, Charles R. Cannan, Verghese Mathew, David R. Holmes, & Amir Lerman. (1996). Evaluation of patients with minimally obstructive coronary artery disease and angina. International Journal of Cardiology. 53(3). 203–208. 41 indexed citations
15.
Cannan, Charles R., et al.. (1996). Echocardiographic identification of commissural calcium: A simple but effective predictor of outcome after percutaneous mitral balloon valvuloplasty. Journal of the American College of Cardiology. 27(2). 238–238. 12 indexed citations
16.
Cannan, Charles R., Stuart T. Higano, David R. Holmes, Kirk N. Garratt, & Amir Lerman. (1996). Beyond the Coronary Angiogram: Further Evaluation of the Coronary Vasculature and Endothelial Function. Journal of Interventional Cardiology. 9(2). 153–161. 5 indexed citations
17.
Cannan, Charles R., et al.. (1996). Altered coronary endothelial function in a patient with asymptomatic left ventricular dysfunction. International Journal of Cardiology. 53(2). 147–151. 11 indexed citations
18.
Cannan, Charles R., Roland R. Brandt, John C. Burnett, & Amir Lerman. (1995). 979-37 Endothelin-1 at Pathophysiological Concentrations Induces Coronary Vasoconstriction via the ET-A Receptors. Journal of the American College of Cardiology. 25(2). 262A–262A. 1 indexed citations
19.
Cannan, Charles R., Guy S. Reeder, Kent R. Bailey, L. Joseph Melton, & Bernard J. Gersh. (1995). Natural History of Hypertrophic Cardiomyopathy. Circulation. 92(9). 2488–2495. 161 indexed citations
20.
Cannan, Charles R., et al.. (1991). Thoracic Manifestations After Esophageal Variceal Sclerotherapy. Mayo Clinic Proceedings. 66(7). 727–732. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026